Insight

Runcie C.W. Chidebe Shared Highlights from ASCO 2025

Runcie C.W. Chidebe/LinkedIn

Jun 3, 2025, 14:49

Runcie C.W. Chidebe Shared Highlights from ASCO 2025

Runcie C.W. Chidebe, Executive Director of Project PINK BLUE, shared a post on LinkedIn:

“Dear American Society of Clinical Oncology (ASCO)

This is the best picture of ASCO 25 Day 3.

So excited to meet with our partners from From Testing to Targeted Treatments (FT3) Helena Harnik, MBA and Silvia Bornengo.

Our study titled “Patient engagement in accelerating care level activation of precision medicine with patient educational materials in Nigeria: A pilot study” was accepted by ASCO25.

Our partnership with FT3 is helping to drive more conversations on access to precision medicine and clinical trials in Nigeria.

In a few days, we will be premiering Blood In My Stool documentary at the Patient Engagement Open Forum. Thank you so much, Silvia, Helena, Ozioma Uzodinma, and many other The Synergist team. You all rock.”

ASCO

More posts featuring Runcie C.W. Chidebe on OncoDaily.

ASCO ASCO 2025 Blood In My Stool From Testing to Targeted Treatments FT3 Helena Helena Harnik Ozioma Uzodinma Patient Engagement Open Forum Project Pink Blue Silvia Silvia Bornengo Synergist team

20 Posts Not to Miss from ASCO 2025

Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?

Agenus and Zydus Group Announced a $141M Strategic Collaboration to Advance the Manufacturing and Global Development of BOT/BAL

15 Posts Not to Miss from the 4th Day of ASCO 2025

15 Posts Not to Miss from the 3rd Day of ASCO 2025